Innovation in the pharmaceutical industry

被引：81

作者：

Horrobin, DF ^{[1
]}

机构：

[1] Laxdale Ltd, Stirling FK7 9JQ, Scotland

来源：

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 2000年 / 93卷 / 07期

关键词：

D O I：

10.1177/014107680009300702

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：341 / 345

页数：5

共 13 条

[1]

ANSELL J, 1997, CONVERGING TARGETS R

[2] FOLATE-DEFICIENCY AND DECREASED BRAIN 5-HYDROXYTRYPTAMINE SYNTHESIS IN MAN AND RAT [J].

BOTEZ, MI ;

YOUNG, SN ;

BACHEVALIER, J ;

GAUTHIER, S .

NATURE, 1979, 278 (5700) :182-183

[3]

Butler D, 1999, NATURE, V402, P705, DOI 10.1038/45312

[4]

COPPEN A, IN PRESS J AFFECT DI

[5]

Drews J, 1999, QUEST TOMORROWS MED

[6] A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice [J].

Freedman, SD ;

Katz, MH ;

Parker, EM ;

Laposata, M ;

Urman, MY ;

Alvarez, JG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13995-14000

[7]

Horrobin D. F., 1996, Pharmaceutical Medicine (London), V10, P29

[8]

HORROBIN DF, 1991, J PHARM MED, V2, P69

[9] How many leads from HTS? [J].

Lahana, R .

DRUG DISCOVERY TODAY, 1999, 4 (10) :447-448

[10]

LOFTUS P, 1994, SCRIP MAGAZINE JUL, P3

← 1 2 →